Yaws

The Lancet

Volumn 381, Issue 9868, 2013, Pages 763-773

  Mitjà, Oriol ^a,b   Asiedu, Kingsley ^c   Mabey, David ^d  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Lihir Medical Centre International SOS   (Papua New Guinea)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; DOXYCYCLINE; ERYTHROMYCIN; TETRACYCLINE;

AFRICA; ANTIBIOTIC THERAPY; ASIA; BONE LESION; CLINICAL FEATURE; CONFERENCE PAPER; DRUG SAFETY; ECUADOR; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; PAPUA NEW GUINEA; PRIORITY JOURNAL; SKIN DEFECT; SYPHILIS; TREATMENT FAILURE; TREPONEMA PALLIDUM; TREPONEMA PALLIDUM PERTENUE; VOMITING; WORLD HEALTH ORGANIZATION; YAWS;

EID: 84874447366     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)62130-8     Document Type: Conference Paper

References (143)

1. Piso W, Marcgrave G. Historia naturalis Brasiliae. Amsterdam: Elsevier, 1648: 35-38 (in Latin).
2. Sydenham T. Epistle II: venereal disease. In: The works of Thomas Sydenham, MD. London: The Sydenham Society, 1848-1850: 29-50.
3. Castellani A. On the presence of spirochaetes in two cases of ulcerated parangi (yaws). BMJ 1905; 2: 1280.
4. Goff CW. Syphilis. In: Brothwell DR, Sandison AT, eds. Disease in antiquity. Springfield: Charles C Thomas, 1967: 170-87.
5. Rothschild BM, Hershkovitz I, Rothschild C. Origin of yaws in the Pleistocene. Nature 1995; 378: 343-44.
6. de Melo FL, de Mello JC, Fraga AM, Nunes K, Eggers S. Syphilis at the crossroad of phylogenetics and paleopathology. PLoS Negl Trop Dis 2010; 4: e575.
7. Harper KN, Ocampo PS, Steiner BM, et al. On the origin of the treponematoses: a phylogenetic approach. PLoS Negl Trop Dis 2008; 2: e148.
8. Hudson EH. Treponematoses and African slavery. Br J Vener Dis 1964; 40: 43-52.
9. Fribourg-Blanc A, Mollaret HH. Natural treponematosis of the African primate. Primates Med 1969; 3: 113-21.
10. Sepetjian M, Guerraz F T, Salussola D, Thivolet J, Monier JC. Contribution to the study of the treponeme isolated from monkeys by A. Fribourg-Blanc. Bull World Health Organ 1969; 40: 141-51 (in French).
11. Knauf S, Batamuzi EK, Mlengeya T, et al. Treponema infection associated with genital ulceration in wild baboons. Vet Pathol 2012; 49: 292-303.
12. Mulligan CJ, Norris SJ, Lukehart SA. Molecular studies in Treponema pallidum evolution: toward clarity? PLoS Negl Trop Dis 2008 23; 21: e184.
13. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12: 187-209.
14. Centurion-Lara A, Molini B, Godornes C, et al. Molecular differentiation of Treponema pallidum subspecies. J Clin Microbiol 2006; 44: 3377-80.
15. Mikalová L, Strouhal M, Cejková D, et al. Genome analysis of Treponema pallidum subsp. pallidum and subsp. pertenue strains: most of the genetic differences are localized in six regions. PLoS One 2010 29; 5: e15713.
16. Ovcinniko NM, Delektorskij VV. Treponema pertenue under the electron microscopes. Br J Vener Dis 1970; 46: 349-79.
17. Engelkens HJ, Vuzevski VD, ten Kate FJ, van der Heul P, van der Sluis JJ, Stolz E. Ultrastructural aspects of infection with Treponema pallidum subspecies pertenue (Pariaman strain). Genitourin Med 1991; 67: 403-07.
18. Liu J, Howell JK, Bradley SD, Zheng Y, Zhou ZH, Norris SJ. Cellular architecture of Treponema pallidum: novel flagellum, periplasmic cone, and cell envelope as revealed by cryo electron tomography. J Mol Biol 2010; 403: 546-61.
19. Izard J, Renken C, Hsieh CE, et al. Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete. J Bacteriol 2009; 191: 7566-80.
20. Norris SJ, Larsen SA. Treponema and other host-associated spirochetes. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington DC: ASM Press, 1995: 636-51.
21. Charon NW, Goldstein SF. Genetics of motility and chemotaxis of a fascinating group of bacteria: the spirochetes. Ann Rev Genet 2002; 36: 47-73.
22. LaFond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev 2006; 19: 29-49.
23. Magnuson HJ, Eagle H, Fleischman R. The minimal infectious inoculum of Spirochaeta pallida (Nichols strain) and a consideration of its rate of multiplication in vivo. Am J Syph Gonorrhea Vener Dis 1948; 32: 1-18.
24. Pearce L, Brown WH. Distinctive characteristics of infections produced by Treponema pertenue in the rabbit. J Exp Med 1925; 41: 673-90.
25. Stamm L. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob Agents Chemother 2010; 54: 583-89.
26. Stamm LV, Bassford PJ Jr. Cellular and extracellular protein antigens of Treponema pallidum synthesized during in vitro incubation of freshly extracted organisms. Infect Immun 1985; 47: 799-807.
27. Stamm L, Stapleton J, Bassford P. In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum. Antimicrob Agents Chemother 1988; 32: 164-69.
28. Rosen T. Nonvenereal treponematoses. In: Yu VL, Merigan TC Jr, Barriere SL, eds. Antimicrobial therapy and vaccines. Baltimore: Williams and Wilkins, 1998: 471-73.
29. Norris SJ, Edmondson DG. In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). Antimicrob Agents Chemother 1988; 32: 68-74.
30. Cejková D, Zobaníková M, Chen L, et al. Whole genome sequences of three Treponema pallidum ssp. pertenue strains: yaws and syphilis treponemes differ in less than 0·2% of the genome sequence. PLoS Negl Trop Dis 2012; 6: e1471.
31. Centurion-Lara A, Castro C, Castillo R, et al. The flanking regions sequences of the 15-kDa lipoprotein gene differentiate pathogenic treponemes. J Infect Dis 1998; 177: 1036-40.
32. Cameron CE, Castro C, Lukehart SA, et al. Sequence conservation of glycerophosphodiester phosphodiesterase among Treponema pallidum strains. Infect Immun 1999; 67: 3168-70.
33. Cameron CE, Lukehart SA, Castro C, et al. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92. J Infect Dis 2000; 181: 1401-13.
34. Centurion-Lara A, Sun E, Barrett L, et al. Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates. J Bacteriol 2000; 182: 2332-35.
35. Harper KN, Liu H, Ocampo PS, et al. The sequence of the acidic repeat protein (arp) gene differentiates venereal from nonvenereal Treponema pallidum subspecies, and the gene has evolved under strong positive selection in the subspecies that causes syphilis. FEMS Immunol Med Microbiol 2008; 53: 322-32.
36. Pillay A, Chen CY, Reynolds MG, et al. Laboratory-confirmed case of yaws in a 10-year-old boy from the Republic of the Congo. J Clin Microbiol 2011; 49: 4013-15.
37. Noordhoek GT, Hermans PWM, Paul AN, et al. Treponema pallidum subspecies pallidum and Treponema pallidum subspecies pertenue (CDC 2575) differ in at least one nucleotide: comparison of two homologous antigens. Microb Pathogenesis 1989; 6: 29-42.
38. Wicher K, Wicher V, Abbruscato F, Baughn RE. Treponema pallidum subsp. pertenue displays pathogenic properties different from those of T. pallidum subsp. pallidum. Infect Immun 2000; 68: 3219-25.
39. Thornburg R, Baseman J. Comparison of major protein antigens and protein profiles of Treponema pallidum and Treponema pertenue. Infect Immun 1983; 42: 623-27.
40. Schell RF, Le Frock JL, Babu JP, Chan JK. Use of CB hamsters in the study of Treponema pertenue. Br J Vener Dis 1979; 55: 316-19.
41. Alder JD, Daugherty N, Harris ON, Liu H, Steiner BM, Schell RF. Phagocytosis of Treponema pallidum pertenue by hamster macrophages on membrane filters. J Infect Dis 1989; 160: 289-97.
42. Engelkens HJ, ten Kate FJ, Judanarso J, et al. The localisation of treponemes and characterization of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis or early infectious yaws. Genitourin Med 1993; 69: 102-07.
43. Engelkens HJ, Vuzevski VD, Judanarso J, et al. Early yaws: a light microscopic study. Genitourin Med 1990; 66: 264-66.
44. Hasselmann CM. Comparative studies on the histopathology of syphilis, yaws, and pinta. Br J Vener Dis 1957; 33: 5-12.
45. Hovind-Hougen K, Birch-Andersen A, Jensen HJ. Ultrastructure of cells of Treponema pertenue obtained from experimentally infected hamsters. Acta Pathol Microbiol Scand B 1976; 84: 101-08.
46. Steiner BM, Schell RF, Harris ON. The effect of C3 depletion on resistance of hamsters to infection with the yaws spirochete. Sex Transm Dis 1986; 13: 245-50.
47. Chan JK, Schell RF, Le Frock JL. Mitogenic responses of hamsters infected with Treponema pertenue. Lack of correlation with passive transfer of resistance. Br J Vener Dis 1982; 58: 292-97.
48. Lukehart SA, Baker-Zander SA, Sell S. Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens. J Immunol 1980; 124: 454-60.
49. Turner TB, Hollander DH. Biology of the treponematoses. Geneva: World Health Organization, 1957.
50. Giacani L, Brandt S, Puray-Chavez M. Comparative investigation of the genomic regions involved in antigenic variation of the TprK antigen among treponemal species, subspecies, and strains. J Bacteriol 2012; 194: 4208-25.
51. McDonnell R. Selection from the works of Abraham Colles, consisting chiefly of his practical observations on the venereal disease, and on the use of Mercury. London: The New Sydenham Society, 1881: 431.
52. Hackett CJ. Extent and nature of the yaws problem in Africa. Bull World Health Organ 1953; 8: 129-82
53. Report of the second international conference on control of yaws: Nigeria 1955. J Trop Med Hyg 1957; 60: 26-38.
54. Castellani A. Experimental investigations on Framboesia tropica (yaws). J Hyg 1907; 7: 558-69.
55. Kumm H, Turner TB. The transmission of yaws from man to rabbits by an insect vector, Hippelates pallipes Loew. Amer J Trop Med 1936; 16: 1-16.
56. Mitjà O, Hays R, Ipai A, et al. Outcome predictors in treatment of yaws. Emerg Infect Dis 2011; 17: 1083-85.
57. Levrero F, Gatti S, Gautier-Hion A, Menard N. Yaws disease in a wild gorilla population and its impact on the reproductive status of males. Am J Phys Anthropol 2007; 132: 568-575.
58. Smith JL, David NJ, Indgin S, et al. Neuroophthalmological study of late yaws and pinta. II. The Caracas project. Br J Vener Dis 1971; 47: 226-51.
59. WHO. Resolutions and decisions: WHA31.58 control of endemic treponematoses. May 24, 1978. http://www.who.int/neglected- diseases/ mediacentre/WHA-31.58-Eng.pdf (accessed Nov 15, 2012).
60. WHO. Yaws and other endemic treponematoses AFR/CD/58. Brazzaville: World Health Organisation, 1986.
61. Capuano C, Ozaki M. Yaws in the Western pacific region: a review of the literature. J Trop Med 2011; 2011: 642832.
62. dos Santos MM, Amaral S, Harmen SP, Joseph HM, Fernandes JL, Counahan ML. The prevalence of common skin infections in four districts in Timor-Leste: a cross sectional survey. BMC Infect Dis 2010; 10: 61.
63. Manning LA, Ogle GD. Yaws in the periurban settlements of Port Moresby, Papua New Guinea. PNG Med J 2002; 45: 206-12.
64. Ministry of Health, Division of Planning and Policy, National Health Statistics Office-Solomon Islands. Annual health report 2007. Technical Report Solomon Islands 2008.
65. de Noray G, Capuano C, Abel M. Campaign to eradicate yaws on Santo island, Vanuatu 2001. Med Trop (Mars) 2003; 63: 159-62 (in French).
66. Fegan D, Glennon MJ, Thami Y, Pakoa G. Resurgence of yaws in Tanna, Vanuatu: time for a new approach? Trop Doct 2010; 40: 68-69.
67. Guerrier G, Marcon S, Garnotel L, et al. Yaws in Polynesia's Wallis and Futuna Islands: a seroprevalence survey. NZ Med J 2011; 29: 29-31.
68. Wirski WR. Surveillance and control of resurgent yaws in the African region. Rev Infect Dis 1985; 7: S227-232.
69. Manirakiza A, Boas SV, Beyam N, et al. Clinical outcome of skin yaws lesions after treatment with benzathine benzylpenicillin in a pygmy population in Lobaye, Central African Republic. BMC Res Notes 2011; 4: 543.
70. Gerstl S, Kiwila G, Dhorda M, et al. Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method. PLoS One 2009; 4: e6338.
71. Touré B, KoffiNM, Assi KP, Ake O, Konan DJ. Yaws in Côte d'lvoire: health problem forgotten and neglected. Bull Soc Pathol Exot 2007; 100: 130-32 (in French).
72. Edorh AA, Siamevi EK, Adanlete FA, et al. Resurgence of endemic yaws in Togo. Cause and eradication approach. Bull Soc Pathol Exot 1994; 87: 17-18 (in French).
73. Anselmi M, Moreire JM, Caicedo C, Guderian R, Tognoni G. Community participation eliminates yaws in Ecuador. Trop Med Int Health 2003; 8: 634-38.
74. Scolnik D, Aronson L, Lovinsky R, et al. Efficacy of a targeted, oral penicillin-based yaws control program among children living in rural South America. Clin Infect Dis 2003; 36: 1232-38.
75. WHO. Eradication of yaws-the Morges strategy. WHO Wkly Epidemiol Rec 2012; 87: 189-94.
76. WHO. First international symposium on yaws control. Bull World Health Organ 1953; 8: 1-148.
77. Powell A. Framboesia: history of its introduction into India with personal observation over 200 initial lesions. Proc R Soc Med 1923; 16: 415-21.
78. Hill K. Non-specific factors in the epidemiology of yaws. Bull World Health Organ 1953; 8: 17-47.
79. Mitjà O, Hays R, Lelngei F, et al. Challenges in recognition and diagnosis of yaws in children in Papua New Guinea. Am J Trop Med Hyg 2011; 85: 113-16.
80. Seghal VN. Leg ulcers caused by yaws and endemic syphilis. Clin Dermatol 1990; 8: 166-74.
81. Gip LS. Yaws revisited. Med J Malaysia 1989; 44: 307-11.
82. Arteaga Ch, Gueghen GE, Richez P, et al. Atteintes osteo-articulaires d'origine parasitaire: les treponematoses osseuses. J Radiol 1998; 79: 1363-66 (in French).
83. Lin SQ. The clinical and the X-ray diagnosis of the bone yaws disease. Chin J Radiol 2006; 40: 414-16.
84. Mitjà O, Hays R, Ipai A, Wau B, Bassat Q. Osteoperiostitis in early yaws: case series and literature review. Clin Infect Dis 2011; 52: 771-74.
85. Engelkens HJ, Vuzevski VD, Stolz E. Nonvenereal treponematoses in tropical countries. Clin Dermatol 1999; 17: 143-52.
86. Perine PL, Hopkins DR, Niemel PLA, St John RK, Causse G, Antal GM. Handbook of endemic treponematoses: yaws, endemic syphilis, and pinta. Geneva: World Health Organization, 1984.
87. Whittet HB, Quiney RE. Nasal manifestations of yaws. J Laryngol Otol 1988; 102: 1147-49.
88. Martinez SA, Mouney DF. Treponemal infections of the head and neck. Otolaryngol Clin North Am 1982; 27: 220-23.
89. Edington GM. Cardiovascular disease as a cause of death in the Gold Coast African. Trans R Soc Trop Med Hyg 1954; 48: 419-25.
90. Roman GC, Roman LN. Occurrence of congenital, cardiovascular, visceral, neurologic, and neuro-ophthalmologic complications in late yaws: a theme for future research. Rev Infect Dis 1986; 8: 760-70.
91. Vorst FA. Clinical diagnoses and changing manifestations of treponemal infection. Rev Infect Dis 1985; 7: 327-31.
92. Autier P, Delcambe JF, Sangare D, et al. Serological and clinical studies of endemic treponematosis in the Republic of Mali. Ann Soc Belge Med Trop 1989; 69: 319-29 (in French).
93. Niemel PLA, Brunings EA, Menke HE. Attenuated yaws in Surinam. Br J Vener Dis 1979; 55: 99-101.
94. Hoang MP, High WA, Molberg KH. Secondary syphilis: a histologic and immunohistochemical evaluation. J Cutan Pathol 2004; 31: 595-99.
95. Satter EK, Tokarz VA. Secondary yaws: an endemic treponemal infection. Pediatr Dermatol 2010; 27: 364-67.
96. Heymans R, van der Helm JJ, de Vries H, Fennema HS, Coutinho RA, Bruisten SM. Clinical value of Treponema pallidum real-time PCR for diagnosis of syphilis. J Clin Microbiol 2010; 48: 497-502.
97. Hudson BJ, Backhouse JL, Tscharke EG. Management of yaws in Papua New Guinea. PNG Med J 1990; 33: 59-65.
98. Garner MF, Backhouse JL. The rapid plasma reagin (circle) card test in yaws. PNG Med J 1972; 5: 171-73.
99. Li HY. Serological study of yaws in Java. Bull World Health Organ 1955; 12: 905-43.
100. de Mello J. Serological studies of yaws in Thailand. Bull World Health Organ 1955; 13: 1003-04.
101. Garner MF, Backhouse JF, Daskolopolous G, Walsh JL. Treponema pallidum haemagglutination test for yaw; comparison with the TPI and FTA-ABS tests. Br J Vener Dis 1972; 48: 479-482.
102. Backhouse JL, Hudson BJ. Evaluation of immunoglobulin G enzyme immunoassay for serodiagnosis of Yaws. J Clin Microbiol 1995; 33: 1875-78.
103. Herring AJ, Ballard RC, Pope V, et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 2006; 82: 7-12.
104. Mabey D, Peeling RW, Ballard R, et al. Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis. Sex Transm Inf 2006; 82: 13-16.
105. Castro AR, Esfandiari J, Kumar S, et al. Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J Clin Microbiol 2010; 48: 4615-19.
106. Yin YP, Chen XS, Wei WH, et al. A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis: a multisite evaluation study in China. Clin Infect Dis (in press).
107. Noordhoek GT, Cockayne A, Schouls LM, Meloen RH, Stolz E, van Embden JD. A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and yaws. J Clin Microbiol 1990; 28: 1600-07.
108. Baker-Zander SA, Lukehart SA. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue. Infect Immun 1983; 42: 634-38.
109. Noordhoek G, Wieles B, Sluis J, Embden J. Polymerase chain reaction and synthetic DNA probes: a means of distinguishing the causative agents of syphilis and yaws? Infect Immun 1990; 58: 2011-13.
110. Eagle H, Fleishman R. The relative antisyphilitic activity of penicillins F, G, K, and X and of bacitracin, based on the amounts required to abort early syphilitic infections in rabbits. J Bacteriol 1948; 55: 341-46.
111. WHO. Yaws: a forgotten disease. Geneva: World Health Organization, 2012. http://www.who.int/neglected-diseases/diseases/yaws/en/index.html (accessed Jan 16, 2012).
112. Backhouse JL, Hudson BJ, Hamilton PA, Nesteroff SI. Failure of penicillin treatment of yaws on Karkar Island, Papua New Guinea. Am J Trop Med Hyg 1998; 59: 388-92.
113. Mitjà O, Hays R, Ipai A, et al. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 2012; 379: 342-47.
114. Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst Rev 2011; 3: CD001860.
115. Ampofo O, Findlay GM. Aureomycin in the treatment of yaws and tropical ulcer in Africa. Nature 1950; 165: 398-99.
116. Loughlin EH, Joseph A, Schaeffer K. Aureomycin in the treatment of yaws. Am J Trop Med Hyg 1951; 31: 20-23.
117. Hill KR. The modern treatment of frambesia (yaws). West Indian Med J 1951; 1: 81-92.
118. Brown WJ, Simpson WG, Moore MB, Price EV, Weinstein S. Oral propionyl erythromycin in treating early syphilis. Public Health Rep 1963; 78: 911-17.
119. Mabey D. Oral azithromycin for treatment of yaws. Lancet 2012; 379: 295-97.
120. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351: 154-58.
121. Marra CM, Colina AP, Godornes C, et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis 2006; 194: 1771-73.
122. Ito S, Shimada Y, Yamaguchi Y, et al. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect 2011; 87: 412-14.
123. Kiddugavu MG, Kiwanuka N, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 2005; 32: 1-6.
124. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353: 1236-44.
125. Van Damme K, Behets F, Ravelomanana N, et al. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis 2009; 36: 775-76.
126. Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23s rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 2000; 44: 806-07.
127. Matejková P, Flasarová M, Zákoucká H, et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol 2009; 58: 832-36.
128. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45: 1-12.
129. Rein CR. Treatment of yaws in the Haitian peasant. J National Med Ass 1949; 41: 60-65.
130. Meheus AZ, Narain JP, Asiedu KB. Endemic treponematoses. In: Cohen J, Powderly SM, Opal WG, eds. Infectious diseases, 3rd edn. London: Elsevier, 2010.
131. Medina R. Evolutive serological responses in patients with buba. Arch Venez Med Trop Parasitol Med 1959; 3: 290-97 (in Spanish).
132. WHO. Elimination of yaws in India. Wkly Epidemiol Rec 2008; 15: 125-32.
133. Hinman AR, Hopkins DR. Lessons from previous eradication programs. In: Dowdle WR, Hopkins DR, eds. The eradication of infectious diseases: report of the Dahlen Workshop on the Eradication of Infectious Diseases. Chichester: John Wiley & Sons, 1988: 19.
134. Hackett CJ, Guthe T. Some important aspects of yaws eradication. Bull World Health Organ 1956; 15: 869-96.
135. Zahra A.Yaws eradication campaign in Nsukka Division, Eastern Nigeria. Bull World Health Organ 1956; 15: 911-35.
136. WHO. Informal Consultation on Yaws. Geneva: World Health Organization, 24-26 Jan, 2007. http://www.who.int/neglected- diseases/diseases/ic24-26- jan2007.pdf (accessed Jan 16, 2012).
137. WHO. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation-executive summary. Geneva: World Health Organization, 2012.
138. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases. Geneva: World Health Organization, 2013.
139. The Carter Center. Summary of the twentieth meeting of the International Task Force for Disease Eradication (II). http://www. cartercenter.org/resources/ pdfs/news/health-publications/itfde/ITFDE-summary-112712.pdf (accessed Jan 16, 2013).
140. Muniz ES. "Is a shot alone enough?": concepts of health, hygiene, and nutrition and the Program to Eradicate Yaws in Brazil, 1956-1961. Hist Cienc Saude Manguinhos 2012; 19: 197-216 (in Portuguese).
141. Meheus A. Integration of yaws control and primary health care. Rev Infect Dis 1985; 7: S284-88.
142. Abdolrasoli A, Croucher A, Hemmati Y, et al. A case of endemic syphilis in Iran. Emerg Infect Dis 2013; 19: 162-63.
143. Fanella S, Kadkhoda K, Shuel M, Tsang R. Local transmission of imported endemic syphilis, 2011. Emerg Infect Dis 2012; 18: 1002-04.